How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond

4:30 PM - 5:55 PM (PDT), Tuesday, June 9, 2020
Search General Info
Search Education
Search Partnering Companies
Selecting a location is an early and critical decision when starting a company or entering a new geographic market. A biotechnology ecosystem combines physical infrastructure with a community of expertise to reduce operational risks and to accelerate achievement of business development goals. The session will detail how Japan’s Shonan Health Innovation Park launched in 2018 by leveraging Takeda’s expertise and now includes about 100 diverse companies from around the world building an open innovation system. Panelists will explain the dimensions to prioritize when choosing an ecosystem to help your organization grow faster. Panelists have expertise working with a variety of different innovation incubation models.
Sponsored By
General Manager of Shonan Health Innovation Park
Takeda Pharmaceutical Company Ltd.
Head JLABS @ Shanghai
Johnson & Johnson Innovation
President, CEO, Co-Founder
AI Dynamics Inc.
Chief Financial Officer & Administrative Partner
Mission BioCapital
CEO and President
Headland Strategy Group
Chief Operating Officer, Executive Vice President
Associate Vice Chancellor for Public Programs and Dean of Extension
University of California, San Diego